US 7824681
Human monoclonal antibodies that specifically bind IGF-II
granted A61KA61K2039/505A61P
Quick answer
US patent 7824681 (Human monoclonal antibodies that specifically bind IGF-II) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61P, A61P43/00